Overview
Sedation for Patients Undergoing Endoscopic Retrograde Cholangiopancreatography
Status:
Completed
Completed
Trial end date:
2019-11-14
2019-11-14
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study was performed to evaluate the role of BIS monitored sedation in reducing the dose of propofol and to know the effectiveness of pre-procedure administration of intravenous diclofenac sodium along with topical pharyngeal anesthesia in reducing the dose of propofol in patients undergoing endoscopic retrograde cholangiopancreatography.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Institute of Liver and Biliary Sciences, IndiaTreatments:
Diclofenac
Lidocaine
Propofol
Criteria
Inclusion Criteria:1. Age between 18-65 yrs
2. ASA I & II
Exclusion Criteria:
1. Age < 18 yrs & > 65 yrs
2. ASA III & IV patients
3. Chronic Liver Disease
4. Pregnant patients
5. Patients with a history of (H/O) Drug abuse
6. Patients refusing consent
7. H/o Acute kidney injury
8. H/o allergy to propofol / lidocaine/ NSAIDS
9. Post liver transplant patients
10. Patients with h/o egg allergy